FDA Approves OJEMDA as the First Targeted Therapy for Pediatric Low-Grade Glioma with BRAF Alterations
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib), marking...
Knowledge and News for the Global Fight Against Cancer.
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib), marking...
The Great Cycle Challenge (GCC) has officially entered its second decade as a cornerstone of...
The fight against pediatric bone cancer has reached a significant turning point as CureSearch for...
As the autumn air signals the traditional return to the classroom, the seasonal transition carries...
In a significant expansion of global efforts to combat the most lethal forms of childhood...
St. Louis, MO — In a significant advancement for the field of pediatric oncology, CureSearch...
Camp Norden, a specialized summer program designed for children and adolescents impacted by cancer, continues...
The reality of pediatric oncology remains one of the most significant challenges in modern medicine,...
In an unprecedented display of philanthropic endurance, Frank Gioscia, a 73-year-old resident of the Great...
Luke Schoenbauer, a doctoral candidate in the physical therapy program at the University of Minnesota,...